BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 22966085)

  • 21. Polymorphisms in mannan-binding lectin (MBL)-associated serine protease 2 affect stability, binding to MBL, and enzymatic activity.
    Thiel S; Kolev M; Degn S; Steffensen R; Hansen AG; Ruseva M; Jensenius JC
    J Immunol; 2009 Mar; 182(5):2939-47. PubMed ID: 19234189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial Recurrence of 3MC Syndrome in Consanguineous Families: A Clinical and Molecular Diagnostic Approach With Review of the Literature.
    Gardner OK; Haynes K; Schweitzer D; Johns A; Magee WP; Urata MM; Sanchez-Lara PA
    Cleft Palate Craniofac J; 2017 Nov; 54(6):739-748. PubMed ID: 27356087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elucidation of the substrate specificity of the MASP-2 protease of the lectin complement pathway and identification of the enzyme as a major physiological target of the serpin, C1-inhibitor.
    Kerr FK; Thomas AR; Wijeyewickrema LC; Whisstock JC; Boyd SE; Kaiserman D; Matthews AY; Bird PI; Thielens NM; Rossi V; Pike RN
    Mol Immunol; 2008 Feb; 45(3):670-7. PubMed ID: 17709141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Essential role of mannose-binding lectin-associated serine protease-1 in activation of the complement factor D.
    Takahashi M; Ishida Y; Iwaki D; Kanno K; Suzuki T; Endo Y; Homma Y; Fujita T
    J Exp Med; 2010 Jan; 207(1):29-37. PubMed ID: 20038603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissociation and re-association studies on the interaction domains of mannan-binding lectin (MBL)-associated serine proteases, MASP-1 and MASP-2, provide evidence for heterodimer formation.
    Paréj K; Hermann A; Donáth N; Závodszky P; Gál P; Dobó J
    Mol Immunol; 2014 May; 59(1):1-9. PubMed ID: 24424083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The control of the complement lectin pathway activation revisited: both C1-inhibitor and antithrombin are likely physiological inhibitors, while α2-macroglobulin is not.
    Paréj K; Dobó J; Závodszky P; Gál P
    Mol Immunol; 2013 Jul; 54(3-4):415-22. PubMed ID: 23399388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of the alternative complement pathway by mannose-binding lectin via a C2-bypass pathway.
    Tateishi K; Matsushita M
    Microbiol Immunol; 2011 Nov; 55(11):817-21. PubMed ID: 21831201
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toward a structure-based comprehension of the lectin pathway of complement.
    Kjaer TR; Thiel S; Andersen GR
    Mol Immunol; 2013 Dec; 56(4):413-22. PubMed ID: 23911397
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assays for the functional activity of the mannan-binding lectin pathway of complement activation.
    Thiel S; Møller-Kristensen M; Jensen L; Jensenius JC
    Immunobiology; 2002 Sep; 205(4-5):446-54. PubMed ID: 12396006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative characterization of the activation steps of mannan-binding lectin (MBL)-associated serine proteases (MASPs) points to the central role of MASP-1 in the initiation of the complement lectin pathway.
    Megyeri M; Harmat V; Major B; Végh Á; Balczer J; Héja D; Szilágyi K; Datz D; Pál G; Závodszky P; Gál P; Dobó J
    J Biol Chem; 2013 Mar; 288(13):8922-34. PubMed ID: 23386610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective inhibition of the lectin pathway of complement with phage display selected peptides against mannose-binding lectin-associated serine protease (MASP)-1 and -2: significant contribution of MASP-1 to lectin pathway activation.
    Kocsis A; Kékesi KA; Szász R; Végh BM; Balczer J; Dobó J; Závodszky P; Gál P; Pál G
    J Immunol; 2010 Oct; 185(7):4169-78. PubMed ID: 20817870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Murine serine proteases MASP-1 and MASP-3, components of the lectin pathway activation complex of complement, are encoded by a single structural gene.
    Stover CM; Lynch NJ; Dahl MR; Hanson S; Takahashi M; Frankenberger M; Ziegler-Heitbrock L; Eperon I; Thiel S; Schwaeble WJ
    Genes Immun; 2003 Jul; 4(5):374-84. PubMed ID: 12847554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MBL-associated serine protease-3 circulates in high serum concentrations predominantly in complex with Ficolin-3 and regulates Ficolin-3 mediated complement activation.
    Skjoedt MO; Palarasah Y; Munthe-Fog L; Jie Ma Y; Weiss G; Skjodt K; Koch C; Garred P
    Immunobiology; 2010 Nov; 215(11):921-31. PubMed ID: 19939495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mannan-binding lectin (MBL)-associated serine protease-1 (MASP-1), a serine protease associated with humoral pattern-recognition molecules: normal and acute-phase levels in serum and stoichiometry of lectin pathway components.
    Thiel S; Jensen L; Degn SE; Nielsen HJ; Gál P; Dobó J; Jensenius JC
    Clin Exp Immunol; 2012 Jul; 169(1):38-48. PubMed ID: 22670777
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of MBL-associated serine protease (MASP) on activation of the lectin complement pathway.
    Takahashi M; Mori S; Shigeta S; Fujita T
    Adv Exp Med Biol; 2007; 598():93-104. PubMed ID: 17892207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TFPI inhibits lectin pathway of complement activation by direct interaction with MASP-2.
    Keizer MP; Pouw RB; Kamp AM; Patiwael S; Marsman G; Hart MH; Zeerleder S; Kuijpers TW; Wouters D
    Eur J Immunol; 2015 Feb; 45(2):544-50. PubMed ID: 25359215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mannose-binding lectin-associated serine protease-1 is a significant contributor to coagulation in a murine model of occlusive thrombosis.
    La Bonte LR; Pavlov VI; Tan YS; Takahashi K; Takahashi M; Banda NK; Zou C; Fujita T; Stahl GL
    J Immunol; 2012 Jan; 188(2):885-91. PubMed ID: 22156595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process.
    Hamad I; Hunter AC; Szebeni J; Moghimi SM
    Mol Immunol; 2008 Dec; 46(2):225-32. PubMed ID: 18849076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular interactions between MASP-2, C4, and C2 and their activation fragments leading to complement activation via the lectin pathway.
    Wallis R; Dodds AW; Mitchell DA; Sim RB; Reid KB; Schwaeble WJ
    J Biol Chem; 2007 Mar; 282(11):7844-51. PubMed ID: 17204478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The mannan-binding lectin pathway and lung disease in cystic fibrosis--disfunction of mannan-binding lectin-associated serine protease 2 (MASP-2) may be a major modifier.
    Olesen HV; Jensenius JC; Steffensen R; Thiel S; Schiøtz PO
    Clin Immunol; 2006 Dec; 121(3):324-31. PubMed ID: 17045845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.